Series B Fundraising Guide: How to Raise in 2026

A Series B round should finance a specific change in the company's risk profile. The right amount is the amount needed to scale a system that already works. The fundraising label matters less than the milestone, the evidence and the financing terms that connect today's company to that milestone.

This guide explains how to decide whether to raise, size the round, prepare evidence, target investors, run a concentrated process, manage diligence and close. Benchmarks are dated and scoped because 2026 is not one market. AI, non-AI software, hardware, biotech, climate and consumer companies can have radically different capital needs and valuations.

What this guide helps you decide

Use this guide to test whether the company's growth system is repeatable, whether its forecast can survive diligence and which capital structure supports the next phase. The practical decision is not simply whether the company is "at Series B." It is whether a priced growth round, an insider extension, debt or continued execution with existing cash produces the best risk-adjusted path.

Finta research note: This article is part of Finta's August 2026 investor research program, which reviewed 615 investor-to-article matches across 425 distinct investors and 806 evidence URLs. The 12 Series B candidates in this guide were chosen using current official strategy and activity evidence. Fund announcements are treated as deployment signals, never as proof of remaining dry powder.

Series B market context in 2026

Carta's July 2026 software sample reported $25 million raised at a $191 million valuation with 12% median dilution. Carta's December 2025 software analysis put Series B dilution at 14%. The Q1 2026 market report said Series B primary pre-money valuations rose 17.2% year over year, but more than 60% of all venture capital in the quarter went to AI companies.

Series B underwriting focuses on repeatability and forecast quality

At Series B, the company should be able to explain not only what grew, but why it grew and what additional capital will reproduce. Investors will test the bridge from historical cohorts and unit economics to the operating plan. A single ARR, growth, or net-retention threshold is not a universal gate, and it is especially inappropriate for consumer, fintech, marketplace, hardware, climate, health, and biotech companies.

Scaling evidence to prepare

Build the operating model from capacity and constraints

A Series B model should show the mechanics of growth. For a sales-led company, connect hiring dates, ramp time, quota capacity, pipeline creation, conversion, contract start, implementation, retention, and cash collection. For a marketplace, model supply, demand, liquidity, frequency, take rate, incentives, and contribution margin. For hardware, include yield, procurement, inventory, installation, service, and working capital. The formulas should reflect how the business operates, not merely extrapolate a top-line percentage.

Track forecast accuracy. Investors will compare prior board plans with actual results, so preserve version history and explain variances. A miss is not automatically disqualifying. A company that identified the cause, changed the plan, and improved its forecasting can be more credible than one that repeatedly resets definitions.

Finance leadership and data discipline

Series B diligence usually requires faster and more consistent answers than an early-stage data room can provide. Assign ownership for monthly close, revenue recognition, KPI definitions, contracts, tax, security, legal matters, and the cap table. Determine whether the company needs a finance leader, controller, FP&A capability, or outside support before the process starts.

Prepare customer-level and cohort-level analyses with clear privacy controls. Reconcile operating metrics to financial statements where possible. If non-GAAP metrics are used, define them, show why they are useful, and avoid presenting them as audited accounting measures. Investors are testing whether the organization can manage a larger capital base and a more complex board cadence.

Primary capital, secondary liquidity, and governance

Some Series B rounds include founder or employee secondary, but it should be separately sized and justified. Primary capital funds the company. Secondary capital buys existing shares and provides liquidity. Mixing the two in one headline obscures runway and dilution. Model who sells, who buys, the price, tax and transfer considerations, and how the transaction affects incentives.

A new lead may request a board seat, information rights, protective provisions, pro rata rights, and an option-pool increase. Evaluate the board as a working group. Adding a respected investor does not help if the resulting governance is slow, duplicative, or misaligned with the company's next operating phase.

The Series C bridge

Define what Series B capital must make true before the next transaction. Possible goals include an efficient second growth channel, international proof, a broader product platform, stronger margins, audit-ready reporting, or a path to self-funding. A plan that depends only on higher revenue without showing improved durability can leave the company larger but not more financeable.

Use market medians as a diagnostic, not a goal. A median describes the middle observation in a defined dataset. It does not tell you what your company is worth, what you should raise or what any investor will offer. Build the plan from cash needs and milestones, then test whether the resulting dilution and valuation are financeable.

What a Series B round is designed to accomplish

At this stage, investors focus on durable growth, cohort quality, efficiency, forecasting, leadership and market position. The financing is commonly structured as priced preferred equity, sometimes with a separately negotiated secondary component. Neither the stage name nor the instrument excuses weak planning. A larger round increases time and options only if the company can deploy it productively.

Write a one-sentence round objective before building a deck: "We are raising [amount] to achieve [measurable operating or technical milestone] by [date], which should make the company ready for [next state]." If the milestone cannot be measured, the use of funds is probably still too vague.

Readiness scorecard

Score each item red, yellow or green. A red item is not always fatal, but it must be explained and reflected in timing, target investors and valuation expectations.

• Problem and market: The pain is urgent, the buyer or user is identifiable and the market can support a venture-scale outcome.
• Product or technical proof: The company has stage-appropriate evidence that it can build the promised product and that users or technical reviewers value it.
• Demand quality: Engagement, retention, revenue, pipeline, clinical evidence or contracted demand is measured consistently and can withstand cohort-level diligence.
• Economics and capital intensity: Gross margin, contribution margin, acquisition cost, payback, burn and working-capital needs are understood for the business model.
• Team: The founders and current leaders can execute the next plan, and the hiring plan identifies the few roles that capital must unlock.
• Governance and records: The cap table, contracts, IP, board approvals, employment files and historical financials are accurate and accessible.

Size the round from milestones, not headlines

Build a monthly operating model with a base case and a downside case. Include hiring start dates, realistic recruiting time, payroll burden, cloud or laboratory cost, working capital, sales-cycle timing, legal and compliance spend, capital equipment and a contingency. The round should fund the plan plus enough time to reach the next fundable proof point before the company is forced back into market.

Then model dilution. For a priced round, compare pre-money and post-money ownership, the new or expanded option pool and any secondary component. For SAFEs or notes, model each security's conversion terms rather than adding cash and guessing at ownership. The cap table after the round matters more than a flattering headline valuation.

Do not confuse an investor's check with the total round. A fund that invests $2 million may join a $10 million round, lead it, or require another investor to price it. The target list and outreach message should reflect the role you want each investor to play.

Prepare the fundraising materials

The deck should make the investment case easy to understand, not hide complexity. A strong sequence covers the problem, product, why now, market, evidence, business model, competition, distribution, team, financial plan, round objective and use of funds. Put detail in an appendix rather than crowding the main narrative.

The data room should be accurate before the process accelerates. Typical folders include corporate records, capitalization, financing documents, material contracts, intellectual property, employment and contractor files, financial statements, operating metrics, tax and compliance records and the plan. Access can be staged, but nothing shared should conflict with the deck or management answers.

Build a metrics dictionary. Define how every important number is calculated, which systems supply it and which periods are comparable. If the company changed a metric definition, preserve both views and explain the transition. Diligence problems often come from inconsistent definitions rather than the underlying business.

Build the investor list around fit

Separate lead candidates from participants. Filter firms by current fund, stage, check, sector, geography, ownership model, partner and competitive conflicts. Recent official activity matters more than an old reputation. An investor that no longer makes new investments at your stage should not remain on the list because it once backed a famous company.

Treat fund size and dry powder as different facts. A recent fund close is a useful deployment signal, but it does not reveal how much capital remains. This guide labels recent funds and current activity from official sources while leaving remaining dry powder as not publicly disclosed unless the manager says otherwise.

The following firms are research starting points for this stage. They are not ranked by returns or prestige. The linked stage page should carry the complete comparison and methodology.

Investor comparison

Warm introductions can improve attention, but relevance determines whether the meeting is worth having. Build several access paths through founders, operators, angels, service providers and portfolio executives. A concise cold message can still work when it contains a precise fit reason, a credible proof point and a clear request.

Run a concentrated process

Fundraising works best as a managed pipeline. Create stages for researched, ready for outreach, contacted, first meeting, partner meeting, diligence, term sheet and closed. Record the owner, next action, date, decision-maker, target check and likely round role. A meeting without a scheduled next step is not progress.

Start with a small calibration set of credible investors. Use the feedback to fix confusing parts of the story, but do not rewrite the company for every opinion. Then launch tightly sequenced waves so interested firms evaluate the company in a comparable window. Be accurate about momentum. Never invent deadlines, offers or investor interest.

Keep operating. Assign one founder to own the process and protect the rest of the team's execution. Send short, consistent updates when evidence changes. New customer wins, product releases, technical milestones and key hires can create legitimate urgency without theater.

Manage diligence and partner meetings

Prepare for the hard questions before the first partner meeting. Why is this market changing now? What evidence could falsify the thesis? Which cohorts are weakest? What stops a well-funded competitor? What breaks in the operating plan? Which hire is hardest? What happens if the next round takes twice as long? Direct answers build more trust than false certainty.

Track every diligence request and keep one source of truth. If an answer changes, update the relevant file and tell active investors. Reference calls should include customers, relevant team members and people who can speak to founder execution. Get permission before sharing personal contact information.

Evaluate term sheets as a system

Price is only one term. Review liquidation preference, participation, dividends, anti-dilution, option-pool treatment, board composition, protective provisions, information rights, pro rata rights, founder vesting, transfer restrictions, secondary sales and closing conditions. The importance of each term depends on the round and jurisdiction.

Compare offers on the post-close cap table and downside outcomes, not just the headline valuation. A higher valuation paired with a larger option-pool increase or stronger downside protection may be less attractive. A qualified startup lawyer should review documents and explain interactions among terms. This guide is not legal or tax advice.

Reference the investor. Ask founders how the firm behaves when a company misses plan, needs an extension, faces an executive issue or evaluates an acquisition. Speak with successful and challenged companies. The relationship may last longer than the current product or market cycle.

Close and communicate

A signed term sheet is not cash. Work backward from the target close through confirmatory diligence, document negotiation, approvals, signatures and funds transfer. Keep a closing checklist with one accountable owner for every item. Do not announce the round until the company and investors agree on timing and the financing has actually closed.

After closing, update the cap table, board materials, hiring plan, budget and investor communications. Translate the fundraising promise into operating milestones. The first board discussion should make tradeoffs explicit and establish how progress will be measured.

Common mistakes

• Raising from a benchmark rather than from a milestone-based operating plan.
• Treating one universal revenue or ARR number as stage readiness across every business model.
• Building a prestige list instead of qualifying current stage, check, partner, geography and conflicts.
• Confusing round size with the check an individual investor can write.
• Sharing inconsistent metrics across the deck, data room and investor conversations.
• Collecting many follower conversations without a credible lead strategy.
• Optimizing only for valuation and ignoring ownership, governance and downside terms.
• Starting too late, when limited runway weakens both operations and negotiating leverage.

Fundraising checklist

• Define the capital milestone and measurable round objective.
• Build base and downside operating plans and determine the required cash.
• Model post-close ownership, option pool and all convertible securities.
• Prepare the deck, appendix, data room and metrics dictionary.
• Build and score the investor list by fit, role and access.
• Prepare partner-meeting answers and reference contacts.
• Launch a sequenced process with clear next actions and truthful momentum.
• Compare term sheets across economics, governance and downside outcomes.
• Complete legal, compliance and closing work with qualified advisers.
• Convert the financing plan into board-approved operating milestones.

Frequently asked questions

How long does a Series B raise take?

There is no reliable universal duration. Preparation, sector, company evidence, existing relationships, market conditions and diligence complexity all matter. Plan enough runway for a longer process than the optimistic case and protect operating execution while fundraising.

How many investors should founders contact for a Series B round?

Use a qualified pipeline, not an arbitrary outreach quota. The list must be large enough to contain multiple credible leads and participants, but each investor should pass stage, check, sector, geography, partner and conflict filters.

Should founders share valuation expectations first?

Founders should know their ownership and financing constraints, but market practice varies. Focus early conversations on the company, the round objective and fit. Coordinate valuation strategy with experienced counsel and advisers, and never accept terms without modeling the full cap table.

What if insiders offer a bridge instead?

Compare the bridge to the operating milestone and next financing risk. A bridge can create time, but it can also postpone a necessary reset. Model the conversion, runway, signaling, governance and downside cases before deciding.

Your next action

Reconcile the last four quarters of actual performance with the operating forecast at the driver level. Separate what improved because of repeatable process from what came from founder effort, one customer, one channel or unusual market conditions. Use that analysis to define the round's capital plan and remove investor candidates that cannot underwrite the company's real scaling model.

Run the process in Finta

Finta helps founders research and prioritize investors, map warm paths, manage the outreach pipeline, organize diligence and keep the fundraising process moving from target list to close.

Related fundraising resources

Compare firms in the Series B investor list, revisit the earlier transition in the Series A fundraising guide, and plan the next capital decision with the Series C fundraising guide and late-stage investor list.

Research methodology and limitations

Finta reviewed the cited Carta data and official investor mandate, fund and investment sources on August 8, 2026. The 12 investor examples are current Series B research candidates, not a universal ranking. Public check ranges are not estimated from round size. Fund announcements and investments establish activity signals only; remaining dry powder is not reported unless the manager publishes it. Benchmark applicability depends on sector, geography, growth quality and capital intensity.

About the author and reviewer

The Finta Editorial Team prepared this guide. Kevin Siskar, CEO of Finta, reviewed it for practical fundraising relevance. Kevin is an early-stage investor and founder-education operator. The review does not replace advice from qualified legal, tax or financial professionals.

Sources

• Carta, VC startup fundraising benchmarks from 1,000 rounds
• Carta, State of Private Markets Q1 2026
• Carta, State of Pre-Seed Q1 2026
• Carta, dilution by venture round
• Y Combinator, SAFE financing documents
• Insight Partners
• IVP
• IVP capital signal
• Accel
• Bessemer Venture Partners
• Lightspeed Venture Partners
• NEA
• Menlo Ventures
• General Catalyst
• Scale Venture Partners
• Sapphire Ventures
• CapitalG
• TCV

Editorial note: This guide provides general information, not legal, tax, financial or investment advice. Financing terms and market conditions change. Consult qualified advisers for your company and jurisdiction.